You can watch PHIOW and buy or sell other stocks, options, ETFs, and crypto commission-free!
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. Read More The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
52 Week High
52 Week Low